TY - JOUR TI - Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia AU - Dholaria, Bhagirathbhai AU - Labopin, Myriam AU - Sanz, Jaime AU - Ruggeri, Annalisa AU - Cornelissen, Jan AU - Labussière-Wallet, Hélène AU - Blaise, Didier AU - Forcade, Edouard AU - Chevallier, Patrice AU - Grassi, Anna AU - Zubarovskaya, Ludmila AU - Kuball, Jürgen AU - Ceballos, Patrice AU - Ciceri, Fabio AU - Baron, Frederic AU - Savani, Bipin N. AU - Nagler, Arnon AU - Mohty, Mohamad T2 - Journal of Hematology & Oncology AB - Allogeneic hematopoietic cell transplantation (allo-HCT) using a mismatched unrelated donor (MMUD) and cord blood transplantation (CBT) are valid alternatives for patients without a fully human leukocyte antigen (HLA)-matched donor. Here, we compared the allo-HCT outcomes of CBT versus single-allele-mismatched MMUD allo-HCT with post-transplant cyclophosphamide (PTCy) in acute myeloid leukemia. DA - 2021/05/03/ PY - 2021 DO - 10.1186/s13045-021-01086-2 DP - BioMed Central VL - 14 IS - 1 SP - 76 J2 - Journal of Hematology & Oncology SN - 1756-8722 UR - https://doi.org/10.1186/s13045-021-01086-2 Y2 - 2021/05/06/21:51:47 KW - Acute leukemia KW - Acute myeloid leukemia KW - Allogeneic hematopoietic cell transplantation KW - Bone marrow KW - Cord blood transplantation KW - Cord blood unit KW - Disease relapse KW - Graft-versus-host disease KW - Human leukocyte antigen KW - Mismatched donor KW - Peripheral blood stem cell KW - Post-transplant cyclophosphamide KW - Toxicity ER -